Combining QSAR classification models for predictive modeling of human monoamine oxidase inhibitors-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Combining QSAR classification models for predictive modeling of human monoamine oxidase inhibitors

Published:2013-01 Issue: Volume:59 Page:75-90
ISSN:0223-5234
Container-title:European Journal of Medicinal Chemistry
language:en
Short-container-title:European Journal of Medicinal Chemistry

Author:

Helguera Aliuska Morales,Pérez-Garrido Alfonso,Gaspar Alexandra,Reis Joana,Cagide Fernando,Vina Dolores,Cordeiro M.Natália D.S.,Borges Fernanda

Publisher

Elsevier BV

Subject

Organic Chemistry,Drug Discovery,Pharmacology,General Medicine

Reference92 articles.

1. The increasing role of monoamine oxidase type B inhibitors in Parkinson's disease therapy;Elmer;Expert Opin. Pharmacother.,2008

2. Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's disease;Chen;Clin. Ther.,2007

3. The therapeutic potential of monoamine oxidase inhibitors;Youdim;Nat. Rev. Neurosci.,2006

4. Selegiline and rasagiline: twins or distant cousins? guidelines;Knudsen Gerber;Consult Pharm.,2011

5. Pharmacotherapy for Parkinson's disease;Chen;Pharmacotherapy,2007

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. One-Pot Sequential Synthesis of Alkenylated Dihydroquinolinones and Hexahydroacridinones in Deep Eutectic Solvent Medium;ACS Omega;2024-08-16

2. Investigation of 3-Phenylcoumarin Derivatives as Potential Multi-target Inhibitors for Human Cholinesterases and Monoamine oxidases: A Computational Approach;Applied Biochemistry and Biotechnology;2024-06-14

3. Unveiling G-protein coupled receptor kinase-5 inhibitors for chronic degenerative diseases: Multilayered prioritization employing explainable machine learning-driven multi-class QSAR, ligand-based pharmacophore and free energy-inspired molecular simulation;International Journal of Biological Macromolecules;2024-06

4. In-silico Screening and ADMET evaluation of Therapeutic MAO-B Inhibitors against Parkinson Disease;Intelligent Pharmacy;2023-12

5. A panorama to mine “bioactive X” against progressive deterioration of liver disease: from NAFLD to HCC;2023-11-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3